Outsourcing is increasing as a percentage of the whole manufacturing capacity due to relatively more of new product manufacturing is outsourced and facilities with products that become generic are non-core and are being divested.
Scope of the Report:
This report studies the Biologics Outsourcing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biologics Outsourcing market by product type and applications/end industries.
The global Biologics Outsourcing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignore ...
Table of Contents
1 Biologics Outsourcing Market Overview
1.1 Product Overview and Scope of Biologics Outsourcing
1.2 Classification of Biologics Outsourcing by Types
1.2.1 Global Biologics Outsourcing Revenue Comparison by Types (2017-2023)
1.2.2 Global Biologics Outsourcing Revenue Market Share by Types in 2017
1.3 Global Biologics Outsourcing Market by Application
1.3.1 Global Biologics Outsourcing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Vaccine & Therapeutics Development
1.3.3 Blood & Blood Related Products Testing
1.3.4 Cellular and Gene Therapy
1.4 Global Biologics Outsourcing Market by Regions
1.4.1 Global Biologics Outsourcing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Bi ...